Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients.

Rheumatology (Oxford, England) - 1 Jul 1999

Huang Q R, Danis V, Lassere M, Edmonds J, Manolios N

Abstract excerpt

OBJECTIVE: We looked for an association between the MvaI polymorphism, a recently reported polymorphism on the promoter of the Apo-1/Fas gene, and rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) patients. METHODS: Two cohorts of Caucasian RA patients (total number = 185) and one cohort of SLE patients (n = 103) were studied. The MvaI polymorphism was typed by polymerase chain reaction and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Arthritis, Rheumatoid
Share to Cohort Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to fas Receptor

Share to Lupus Erythematosus, Systemic

Share to Photosensitivity Disorders

Share to Polymerase Chain Reaction

Share to Promoter Regions, Genetic

Source

Identifiers

PMID: 10461479
DOI: 10.1093/rheumatology/38.7.645

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of a new Apo-1/Fas promoter polymorphism in rheumatoid arthritis and systemic lupus erythematosus patients.PMID 10461479Read ↗

Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.Semantic proximity Read ↗

APO1/F AS promoter polymorphism in systemic lupus erythematosus (SLE): significance in clinical expression of the disease.Semantic proximity Read ↗

TNF-308 G/A polymorphism and risk of systemic lupus erythematosus in the Polish population.Semantic proximity Read ↗

Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene.Semantic proximity Read ↗

Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis.Semantic proximity Read ↗

Association of FAS and FAS ligand genes polymorphism and risk of systemic lupus erythematosus.Semantic proximity Read ↗

Association of FAS gene polymorphisms with systemic lupus erythematosus: A case-control study and meta-analysisSemantic proximity Read ↗

Tumor necrosis factor alpha promoter polymorphism -308 G/A in Brazilian patients with systemic lupus erythematosus.Semantic proximity Read ↗

A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus.Semantic proximity Read ↗

Fas gene polymorphisms in systemic lupus erythematosus and serum levels of some apoptosis-related molecules.Semantic proximity Read ↗

Evaluation of the apo-1/Fas promoter mva I polymorphism in multiple sclerosis.Semantic proximity Read ↗

Investigation of the -1377 polymorphism on the Apo-1/Fas promoter in systemic lupus erythematosus patients using allele-specific amplification.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.